Microbiology

Cefmatilen is an orally-active cephalosporin antibiotic that targets bacterial cell wall synthesis. It demonstrates significant antimicrobial activity against a range of Gram-positive and Gram-negative bacteria, including Streptococcus pyogenes and Neisseria gonorrhoeae. This compound is useful for research applications focused on antibiotic resistance and the mechanisms of bacterial pathogenesis.

Helvecardin B is a glycopeptide antibiotic that exerts its effects by disrupting bacterial cell wall synthesis. It demonstrates potent activity against both aerobic and anaerobic Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Helvecardin B is useful in microbiological studies and antibiotic resistance research, contributing to the understanding of mechanisms underlying bacterial infections and treatment strategies.

Saframycin C is an analog of the antibiotic soramycin, characterized as the 0-methyl derivative of racemomycin B. This compound exhibits significant antibacterial activity, making it a valuable tool for microbiological research. Its unique structure and mode of action provide insights into antibiotic mechanisms and potential therapeutic applications in combating resistant bacterial strains.

Pyrrolomycin C is an antibiotic that targets bacterial ribosomes, inhibiting protein synthesis and thereby exerting antimicrobial activity. Isolated from Actinosporangium species, it demonstrates potent effects against a range of Gram-positive bacteria. Pyrrolomycin C is valuable for research applications in microbiology and antibiotic development.

Micacocidin B is an antibiotic derived from Pseudomonas sp. No. 57, with potent activity against Mycoplasma species. This compound serves as a valuable research tool for studying bacterial infections and developing antimicrobial strategies. Its efficacy against specific pathogens makes it a critical reagent for microbiological investigations.

Napyradiomycin B3 is an antibiotic with a primary mechanism of action against Gram-positive bacteria and mycobacterial species. It exhibits potent antibacterial activity, making it a valuable tool for research in infectious diseases and the development of new antimicrobial agents. Its unique properties support investigations into bacterial resistance and the efficacy of novel therapeutic strategies.

Enamidonin is a lipopeptide antibiotic that primarily targets epidermal growth factor (EGF) signaling pathways. It demonstrates a significant ability to inhibit EGF-dependent [3H] thymidine incorporation in Balb/MK cells, with an IC50 of 10 µg/mL. Additionally, Enamidonin has the capacity to restore the altered morphology of SRCTS-NRK cells to a normal flat configuration, with an effective dose (ED50) of 10 µg/mL. This compound is valuable for research applications exploring cell signaling and morphology in the context of antibiotic activity.

Pyloricidin D is an antibiotic targeting Helicobacter pylori, derived from Bacillus sp. HC-70. It exhibits potent antimicrobial activity against this pathogen, making it valuable for research focused on gastrointestinal infections and antibiotic development. Its mechanism of action contributes to the understanding of bacterial resistance and the viability of alternative therapeutic strategies.

Menoxymycin A is an antitumor antibiotic that exerts its effects primarily through cytotoxic activity. It demonstrates potent inhibition of KB and N18-RE-105 cancer cell lines, with IC50 values of 0.86 μM and 0.14 μM, respectively. This compound serves as a valuable tool for research into cancer therapeutics and mechanistic studies of antibiotic action against tumor cells.

Streptothricin F is a bactericidal antibiotic that primarily targets the 30S subunit of the 70S ribosome, disrupting protein synthesis in susceptible bacteria. It demonstrates rapid bactericidal activity against highly drug-resistant, carbapenem-resistant Enterobacterales (CRE), with MIC50 and MIC90 values of 2 and 4 μM, respectively, and is also effective against Acinetobacter baumannii. This compound is valuable for research applications focused on antibiotic resistance and the development of new antimicrobial therapies.

11-Deoxy-13-deoxodaunorubicin is an anthracycline antibiotic that primarily targets bacterial and tumor cells. This compound exhibits significant antibacterial activity against both Gram-positive and Gram-negative bacteria, as well as antitumor effects. It is commonly utilized in research applications related to oncology and microbiology.

Halomicin A is an ansamycin antibiotic known for its broad-spectrum antibacterial properties. It exhibits activity against both Gram-positive and Gram-negative bacteria, making it a valuable reagent for researching antibiotic resistance and microbial inhibition. This compound is essential for investigations into bacterial pathogenesis and the development of new antimicrobial therapies.

(-)-cis-Myrtanol is a terpenoid compound with notable antibacterial properties, primarily targeting harmful gut bacteria such as Bifidobacterium bifidum. This compound, derived from Artemisia dracunculus, demonstrates effective antimicrobial activity, making it a valuable reagent for research in gastrointestinal health and antibiotic development. Its potential applications in microbiological studies further highlight its significance in understanding gut microbiota interactions and therapeutic strategies.

Actinobolin hemisulfate is an antibiotic that primarily inhibits protein synthesis by targeting both bacterial and eukaryotic ribosomes. This compound demonstrates significant antibacterial activity against Mycobacterium smegmatis and Escherichia coli, with IC50 values of 19.2 μmol/L and 27.9 μmol/L, respectively. Additionally, it acts on rabbit reticulocyte lysate with an IC50 of 288 μmol/L. Actinobolin hemisulfate is valuable for research applications focusing on bacterial resistance and protein synthesis inhibition mechanisms.

Lactoquinomycin B is an antitumor antibiotic that exerts its effects by targeting and inhibiting various cancer cell lines. It demonstrates significant activity against Gram-positive bacteria and exhibits weak effects on some Gram-negative bacteria, though it is ineffective against fungi. In cell viability assays, Lactoquinomycin B inhibits lymphoma L5178Y progenitor cells, as well as Adriamycin-resistant and Bleomycin-resistant cell lines, with observed ID50 values of 0.43, 0.21, and 0.19 μg/mL, respectively, indicating its potential utility in cancer research and antibiotic susceptibility studies.

Elmycin D is an antibiotic derived from Streptomyces cellulosae ssp. griseoincarnatus. It functions by inhibiting bacterial growth, making it a valuable tool in research aimed at studying antimicrobial properties and identifying potential therapeutic agents. This compound is primarily utilized in investigations related to antibiotic resistance and microbial pathogenicity.

2-Hydroxygentamicin C1 is a potent antibiotic belonging to the gentamicin class, targeting both Gram-positive and Gram-negative bacteria. It exhibits significant antibacterial activity, making it suitable for research applications focused on studying bacterial resistance and antibiotic efficacy. This compound is essential for exploring mechanisms of action and therapeutic potential in infectious disease research.

Milbemycin α13 is an antibiotic that exerts its effects by targeting neuronal signaling pathways in nematodes and arthropods. This compound is effective in killing various nematodes and mites, making it valuable for research related to parasitology and pest management. Its mechanism of action offers insights into neurobiology and potential therapeutic strategies against parasitic infections.

Lactonamycin Z is an antitumor antibiotic that exerts its effects primarily through selective inhibition of tumor cell growth. It demonstrates significant cytotoxic activity against human cancer cell lines, including HMO2, MCF7, and Hep G2, with GI50 values of 1.9 μg/mL, 0.85 μg/mL, and 5.11 μg/mL, respectively. While it exhibits weak anti-Gram-positive bacterial activity, its primary research applications lie in the exploration of tumor cell mechanisms and potential therapeutic interventions in cancer treatment.

Liriodenine methiodide is an antibiotic with notable activity against Candida albicans and Saccharomyces cerevisiae. This compound exhibits antimicrobial properties, making it a valuable reagent for research on fungal infections and related mechanisms. Its application extends to studies focused on antibiotic efficacy and resistance patterns in pathogenic yeast.

5-Hydroxymethylblasticidin S is a broad-spectrum antibiotic that targets bacterial ribosomes, disrupting protein synthesis. Derived from Streptomyces setonii, it exhibits potent antimicrobial activity against a variety of Gram-positive and Gram-negative bacteria. This compound is valuable for research applications focused on antibiotic resistance, microbial growth inhibition, and the study of bacterial ribosome function.

Prothracarcin is an antitumor antibiotic that exerts its cytotoxic effect by covalently binding to the C-2 amino group of guanine residues in the minor groove of DNA, leading to disruption of DNA function and ultimately cell death. In addition to its antitumor properties, Prothracarcin also demonstrates antibacterial activity against select Gram-positive and certain Gram-negative bacteria, including Escherichia coli. This dual functionality makes Prothracarcin a valuable reagent in cancer research and studies involving bacterial infections.

Milbemycin β3 is a macrolide antibiotic that targets insect neural mechanisms. It exhibits potent insecticidal activity, effectively controlling harmful agricultural pests, including larvae and other insects. This compound is widely utilized in research applications focused on pest management and agricultural studies.

Argimicin C is an antibiotic derived from Sphingomonas sp. This compound demonstrates significant algicidal activity against various toxic cyanobacteria, exhibiting minimal inhibitory concentrations (MIC) in the low micromolar range. Argimicin C is valuable for research applications focused on algal blooms and the management of harmful cyanobacterial populations.

AM-112 is a potent β-lactamase inhibitor that targets class A, C, and D β-lactamase enzymes, demonstrating IC50 values as low as 0.0002 μg/mL. Its mechanism involves the inhibition of PBP2, a penicillin-binding protein in E. coli, thereby protecting Ceftazidime from enzymatic hydrolysis and enhancing its antibacterial activity against Gram-negative bacteria, enterococci, and staphylococci. AM-112 exhibits favorable pharmacokinetic properties and acid-base stability, making it a valuable tool for research into bacterial infections.

Desmycosin is a macrolide antibiotic known for its potent antibacterial properties. It demonstrates significant activity against Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes, with minimum inhibitory concentration (MIC) values of 4, 1, <0.125, and <0.125 µg/ml, respectively. As an acidic degradation product of tylosin, desmycosin serves as a valuable tool in microbiological research and therapeutic applications targeting these bacterial pathogens.

Erythromycin propionate, a derivative of the macrolide antibiotic erythromycin, primarily targets bacterial protein synthesis. This compound exhibits broad-spectrum antibacterial activity, making it suitable for treating various bacterial infections. However, it is important to note that erythromycin propionate can induce liver toxicity, particularly cholestatic hepatitis, due to its interference with bile acid transport. This compound is valuable in research related to antibiotic efficacy and liver safety assessments.

Ophiobolin D is a terpenoid antibiotic targeting various microbial pathogens. It exhibits notable biological activity against Gram-positive bacteria, mycobacteria, and fungi, with a specific focus on inhibiting certain plant pathogens. While it demonstrates a weaker inhibitory effect on Staphylococcus aureus, Ophiobolin D is valuable for research applications related to antibiotic development and understanding microbial resistance mechanisms.

Tosufloxacin hydrate is an orally active fluoroquinolone antibiotic that primarily targets bacterial DNA gyrase and topoisomerase IV. It exhibits a broad spectrum of antibacterial activity against both gram-positive and gram-negative bacteria. This compound is utilized in research applications to study bacterial resistance mechanisms and the efficacy of fluoroquinolone antibiotics in treating infections.

Pluracidomycin A2 is a carbapenem antibiotic targeting bacterial cell wall synthesis. It exhibits potent antimicrobial activity against both Gram-positive and Gram-negative bacteria, making it a valuable compound for research in antibiotic resistance and bacterial infections. Its unique mechanism of action positions it as a promising candidate for further development in therapeutic applications.

CGP 31523A is a broad-spectrum aminothiazole cephalosporin that targets several Gram-negative bacteria. It demonstrates potent antibacterial activity against Enterobacteriaceae, Neisseria, Haemophilus influenzae, and Streptococcus (excluding Enterococcus faecalis). While CGP 31523A is susceptible to the hydrolytic action of Escherichia coli type Ic β-lactamase, it remains stable against type Ia β-lactamase. This compound is utilized in research focusing on infections caused by Gram-negative bacteria, including those caused by multi-drug resistant strains.

Metronidazole phosphate disodium is a water-soluble prodrug of Metronidazole, primarily acting as an antibiotic. This compound is effective against anaerobic infections, making it a valuable reagent for studying bacterial resistance mechanisms and developing therapies for infectious diseases. Its parenteral formulation enables research applications in pharmacokinetics and drug delivery systems.

A-269A is an antibiotic compound derived from Streptomyces sp., exhibiting notable antimicrobial activity. It works by inhibiting protein synthesis, making it effective against a range of bacterial strains. This compound is valuable for research applications in microbiology and antibiotic susceptibility testing.

Chrymutasin A is a glycosidic antibiotic with notable antitumor properties. It exhibits cytotoxic activity against various cancer cell lines, making it a valuable tool in cancer research. This compound is particularly useful for studying mechanisms of action related to antibiotic resistance and tumor cell survival.

Nodusmicin is a macrolide antibiotic that exhibits activity against both antibiotic-susceptible and antibiotic-resistant strains of Staphylococcus aureus. It demonstrates minimal inhibitory concentration (MIC) values of 125 μg/mL for the UC-76 strain, and 250 μg/mL for both UC-6685 and UC-6690 strains. This compound is significant for research applications involving the mechanisms of antibiotic resistance and the development of new therapeutic strategies against bacterial infections.

16-Hydroxyroridin L-2 is a trichothecene group antibiotic that exhibits significant antitumor activity. As a mycotoxin, it has been shown to inhibit the growth of various cancer cell lines, making it a valuable reagent for cancer research. This compound is useful for studies focusing on the mechanisms of tumor suppression and the exploration of potential therapeutic strategies against malignancies.

Sannamycin K is an aminoglycoside antibiotic that primarily targets bacterial protein synthesis. It exhibits weak antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is suitable for research applications focused on studying antibiotic mechanisms and bacterial resistance.

(E)-Cefodizime is an antibiotic that primarily targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall synthesis. This mechanism of action allows it to exert significant antibacterial activity against a range of bacterial pathogens. (E)-Cefodizime is particularly relevant for research into bacterial infectious diseases and is valuable in studies focusing on preoperative infection prophylaxis.

AR-709 is a diaminopyrimidine antibiotic that targets bacterial pathogens. It demonstrates strong antibacterial activity against Streptococcus pneumoniae, with a minimum inhibitory concentration (MIC) of 0.03 mg/L. AR-709 is suitable for research applications focused on understanding and combating bacterial infections.

Ritipenem is a penicillin antibiotic that targets penicillin-binding proteins with high affinity, demonstrating an IC50 in the ng/mL range. It exhibits significant antibacterial activity, particularly against Haemophilus influenzae, highlighting its potential use in treating bacterial infections. This compound is valuable for research applications focused on antibiotic efficacy and mechanisms of resistance.

Amythiamicin A is a potent antibiotic that primarily targets Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Additionally, it exhibits antimicrobial activity against the malaria parasite Plasmodium falciparum. This compound is valuable for research applications focused on combating resistant bacterial infections and understanding parasitic diseases.

Corynecin I is an antibiotic derived from Corynebacterium hydrocarboclastus, exhibiting potent antimicrobial activity. It is primarily effective against Gram-positive bacteria and plays a critical role in research related to antibiotic development and resistance mechanisms. Additionally, its precursor, D-(-) threo-p-amino phenyl serinol-N-acetylamine, demonstrates a minimal inhibitory effect on Corynecin synthesis from mevalonic acid, providing insights into its biosynthetic pathway.

Fluvirucin B4 is an antibiotic with activity against the influenza A virus. This compound demonstrates antiviral properties, making it useful in research related to influenza infections and the development of antiviral therapies. Its mechanism of action involves inhibition of viral replication, contributing to its effectiveness in combating influenza A virus.

Gilvocarcin M is an antibiotic derived from the bacterium S. gilvotanareus, exhibiting significant activity against Staphylococcus aureus with a minimum inhibitory concentration of 32 µg/ml. Additionally, it demonstrates potent antitumor effects on KB cells, showing an IC50 of 0.52 µg/ml. Its mechanism of action includes intercalation into bacteriophage PM2 DNA, making it a valuable tool for research in infectious diseases and cancer biology.

Arylomycin A1 is a lipohexapeptide antibiotic that targets Gram-positive bacteria. It exhibits potent antibacterial activity by inhibiting the function of bacterial signal peptidases. This compound is valuable for research into antibiotic mechanisms and the development of new therapeutic agents targeting resistant bacterial strains.

Norfloxacin hydrochloride is a broad-spectrum antibacterial agent that targets and inhibits DNA gyrase, thus interfering with bacterial DNA replication and repair. It exhibits activity against a wide range of Gram-positive and Gram-negative bacteria, making it a valuable reagent for microbiological research and the study of bacterial resistance mechanisms. This compound is utilized in the investigation of bacterial infections and the development of new antimicrobial therapies.

MM 47755 (8-O-Methyltetrangomycin; 6-Deoxy-8-O-methylrabelomycin) is a potent antibiotic derived from the actinobacterium Streptomyces. It exhibits significant antibacterial activity, making it a valuable compound for microbiological studies. Research applications include the investigation of bacterial resistance mechanisms and the development of new antimicrobial therapies.

Clavariopsin B is a cyclic depsipeptide antibiotic that exerts antifungal activity. It demonstrates significant efficacy against Candida albicans strains IFO 0583 and ATCC 10231, as well as Aspergillus niger and Aspergillus fumigatus, with minimum inhibitory concentration (MIC) values ranging from 4 to 16 μg/mL. This compound is useful in research applications focusing on fungal infections and the development of new antifungal therapies.

Antibacterial Agent 285 is a cephalosporin antibiotic targeting bacterial cell wall synthesis. It exhibits potent antibacterial activity against gram-negative bacteria, with minimum inhibitory concentrations (MICs) of 0.125-0.5 µg/mL for carbapenem-resistant Acinetobacter baumannii, 0.125-0.5 µg/mL for Klebsiella pneumoniae, and 0.125-2 µg/mL for Pseudomonas aeruginosa. This compound is suitable for research applications related to bacterial infections, including complicated urinary tract infections and kidney infections.

Paldimycin A is an antibiotic derived from Streptomyces paulus, primarily targeting Gram-positive bacteria. This compound disrupts bacterial protein synthesis and alters cell membrane function, leading to its antibacterial activity. Paldimycin A is valuable for research applications focusing on bacterial resistance and the mechanisms of antibiotic action.